Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars

Pharmacists from Fatal Meningitis Outbreak Facing Trial

By MaryBeth DiDonna | January 3, 2017

A former executive at a compounding pharmacy in Massachusetts is headed for trial, after the facility was deemed responsible for a national meningitis outbreak in 2012 that killed 64 and sickened over 700 people. Around half of the victims developed a rare fungal form of meningitis, while the others endured joint or spinal infections.

Barry Cadden, co-founder and head pharmacist of the New England Compounding Center in Framingham, will appear in U.S. District Court in Boston on Jan. 4. He is being charged with 25 counts of murder and other offenses under federal racketeering laws. Jury selection is expected to begin on Jan. 6.

Prosecutors in the case have said that the center used expired ingredients and did not follow cleanliness standards, which resulted in tainted steroid injections.

State officials released a report on Oct. 23, 2012, citing their findings: Water from a leaking boiler collected just outside a cleanroom; floor mats used by technicians were filled with dirt and debris; drugs were shipped out before the company even confirmed they were sterile; among other issues.

The FDA later released a copy of the FDA Form 483 issued to the New England Compounding Center, after observing and confirming contaminated products and listing a number of observations regarding conditions in the cleanroom at NECC’s facility.

Glenn Chin, the supervising pharmacist at NECC who monitored the cleanrooms, is also being charged with 25 counts of second-degree murder and racketeering charges. He will have a separate trial. Federal investigators say that he didn’t properly sterilize or test equipment and concealed the unsafe practices, and was involved in compounding the contaminated methylprednisolone acetate (MPA) that caused the outbreak. An affidavit filed in U.S. District Court alleged that Chin participated in a scheme to fraudulently cause one lot of MPA to be labeled as injectable, meaning that it was sterile and fit for human use. The lot was shipped to Michigan Pain Specialists in Brighton, Mich. After receiving the drug, Michigan Pain Specialists doctors injected it into patients, believing it to be safe. As a result, 217 patients contracted fungal meningitis, and 15 of them died, according to the affidavit.

Chin was arrested at Logan Airport on Sept. 4, 2014, as he was about to board a flight for Hong Kong.

Related Articles Read More >

Enclosures isolate robotic and lab automation processes and equipment
Safely contain airborne particulate with CCS (Controlled Containment System)
Modular cleanlabs feature modular construction
EnviroMax on Blue BG
Enclosures for Lab Automation and Robotics
2021 R&D Global Funding Forecast

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2021 Global Funding Forecast

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars